Corporate Banner
Satellite Banner
Chemical Process Scale Up
Scientific Community
Become a Member | Sign in
Home>News>This Article

Onyx Strengthens Commercial Team

Published: Monday, May 28, 2012
Last Updated: Monday, May 28, 2012
Bookmark and Share
Appointment of Brian Jolly as director of European business development.

Onyx Scientific has bolstered its business development team with the appointment of an experienced new director.

Brian Jolly joins the contract manufacturing organization’s (CMO) UK team as Director of European Business Development and will be responsible for overseeing the company’s sales effort across Europe.

PhD qualified, Brian brings a wealth of experience to the company having spent over 25 years in a range of technical and commercial roles in specialty chemicals and the wider chemical industry.

Operating from MHRA and FDA licensed sites in UK and India, Onyx Scientific supports pharmaceutical and emerging biotech from medicinal chemistry and preclinical through Phase I-III, scaling-up to large scale commercial API production.

Denise Bowser, commercial director head at Onyx Scientific, said: “We are delighted to have Brian on board as he has a huge amount of commercial experience that will no doubt benefit the company’s continued growth.

“Although we have clients across the world, the European market remains a key one. It is therefore essential for us to have this level of expertise on the ground to service clients and potential customers.”

The CMO recently launched a new website ( to reflect the company’s expanded service offering following its acquisition by Ipca Laboratories last year.

Its team in Sunderland, UK, has dovetailed its chemistry services with the scale-up and manufacturing services offered by Ipca in India.

New appointment Brian said: “The thing that attracted me to Onyx Scientific was the company’s ambition for growth. It is a dynamic business with a fantastic reputation for expertise and competence for reliably delivering on its commitments to customers.

“It’s a fantastic new challenge for me and I am convinced this business has a solid foundation on which it can now grow and be recognized as a key player in the global contract manufacturing marketplace.”

Working as a preferred partner of many of the world’s top pharma firms, its UK-based labs deal with complex chemistry and deliver early stage programs involving custom synthesis, lead optimization, process development, solid-state chemistry and GMP API synthesis. It is then able to scale-up, internally tech transfer and provide increased efficiency for clients from its commercial sites in India.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Onyx Scientific to Expand GMP Capability
Expansion aims to support increase in Phase I/II campaigns from clients in Europe and the USA.
Tuesday, April 28, 2015
Onyx to Invest in Continuous Flow Technology
Significant investment into continuous flow manufacturing will allow Onyx's customers to explore alternatives during product research and development programs.
Thursday, June 26, 2014
Solid State Boost at Onyx
Company unveils huge increase in demand for solid-state chemistry services.
Tuesday, December 10, 2013
Onyx to Expand Capabilities
Reach alliance broadens specialist purification, separation services.
Tuesday, August 07, 2012
Scientific News
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Cutting the Cost of Drug-Building Chemicals
EPFL scientists have developed a method to produce aryl-containing amines in a cheap and easily scalable way.
How Cloud Connectivity Can Combat the Reproducibility Crisis
This infographic explains the reproducibility crisis, and how cloud connectivity can help overcome this problem.
Porphyrins as Catalysts in Scalable Organic Reactions
This review covers the most relevant scalable porphyrin-catalysed procedures, showing how these compounds represent broad applications in chemistry.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
New Cancer Fighters Emerge From Lab
Rice University lab simplifies total synthesis of anti-cancer agent.
Pharmacy on Demand
New, portable system can be configured to produce different drugs.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Countless New, Cleaner Uses of Methane
Chemists have demonstrated the potential to use methane as a versatile chemical building block with which to make more complex molecules.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos